3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one

C82H98Cl3N21O7 — CID 161499037

IUPAC3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one
SMILESCC1CCC(Cn2c(N3CCCC3C(C)C)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1.CC1CCC(Cn2c(N3CCCOCC3C)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1.CC1CCC(Cn2c(N3[C@H](C)CC[C@H]3C)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1
InChIInChI=1S/C28H34ClN7O2.C27H32ClN7O3.C27H32ClN7O2/c1-16(2)23-5-4-10-35(23)27-32-21-12-22(26-33-28(37)38-34-26)31-24(19-11-20(29)14-30-13-19)25(21)36(27)15-18-8-6-17(3)7-9-18;1-16-4-6-18(7-5-16)14-35-24-21(31-26(35)34-8-3-9-37-15-17(34)2)11-22(25-32-27(36)38-33-25)30-23(24)19-10-20(28)13-29-12-19;1-15-4-8-18(9-5-15)14-34-24-21(31-26(34)35-16(2)6-7-17(35)3)11-22(25-32-27(36)37-33-25)30-23(24)19-10-20(28)13-29-12-19/h11-14,16-18,23H,4-10,15H2,1-3H3,(H,33,34,37);10-13,16-18H,3-9,14-15H2,1-2H3,(H,32,33,36);10-13,15-18H,4-9,14H2,1-3H3,(H,32,33,36)/t;;15?,16-,17-,18?/m..1/s1
InChIKeyWGPBMRKYTOLBQF-JYQZDUOSSA-N
MW1596.18 g/mol
LogP16.57
Rot. Bonds16

About 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one

3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one (PubChem CID 161499037) has the molecular formula C82H98Cl3N21O7 and a molecular weight of 1596.18 g/mol. Its IUPAC name is 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one.

Molecular Properties

Compound Name3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one
PubChem CID161499037
Molecular FormulaC82H98Cl3N21O7
Molecular Weight1596.18 g/mol
Exact Mass1593.70
IUPAC Name3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one
SMILESCC1CCC(Cn2c(N3CCCC3C(C)C)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1.CC1CCC(Cn2c(N3CCCOCC3C)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1.CC1CCC(Cn2c(N3[C@H](C)CC[C@H]3C)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1
InChIInChI=1S/C28H34ClN7O2.C27H32ClN7O3.C27H32ClN7O2/c1-16(2)23-5-4-10-35(23)27-32-21-12-22(26-33-28(37)38-34-26)31-24(19-11-20(29)14-30-13-19)25(21)36(27)15-18-8-6-17(3)7-9-18;1-16-4-6-18(7-5-16)14-35-24-21(31-26(35)34-8-3-9-37-15-17(34)2)11-22(25-32-27(36)38-33-25)30-23(24)19-10-20(28)13-29-12-19;1-15-4-8-18(9-5-15)14-34-24-21(31-26(34)35-16(2)6-7-17(35)3)11-22(25-32-27(36)37-33-25)30-23(24)19-10-20(28)13-29-12-19/h11-14,16-18,23H,4-10,15H2,1-3H3,(H,33,34,37);10-13,16-18H,3-9,14-15H2,1-2H3,(H,32,33,36);10-13,15-18H,4-9,14H2,1-3H3,(H,32,33,36)/t;;15?,16-,17-,18?/m..1/s1
InChIKeyWGPBMRKYTOLBQF-JYQZDUOSSA-N
XLogP16.57
TPSA326.42 Ų
H-Bond Donors3
H-Bond Acceptors25
Rotatable Bonds16
Heavy Atoms113
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001596.18
LogP ≤ 516.57
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1025

Analyze 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one?
The IUPAC name of 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one (CID 161499037) is 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one.
What is the SMILES notation for 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one?
The canonical SMILES for 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one is CC1CCC(Cn2c(N3CCCC3C(C)C)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1.CC1CCC(Cn2c(N3CCCOCC3C)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1.CC1CCC(Cn2c(N3[C@H](C)CC[C@H]3C)nc3cc(-c4noc(=O)[nH]4)nc(-c4cncc(Cl)c4)c32)CC1.
What is the InChIKey of 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one?
The InChIKey is WGPBMRKYTOLBQF-JYQZDUOSSA-N. The full InChI is InChI=1S/C28H34ClN7O2.C27H32ClN7O3.C27H32ClN7O2/c1-16(2)23-5-4-10-35(23)27-32-21-12-22(26-33-28(37)38-34-26)31-24(19-11-20(29)14-30-13-19)25(21)36(27)15-18-8-6-17(3)7-9-18;1-16-4-6-18(7-5-16)14-35-24-21(31-26(35)34-8-3-9-37-15-17(34)2)11-22(25-32-27(36)38-33-25)30-23(24)19-10-20(28)13-29-12-19;1-15-4-8-18(9-5-15)14-34-24-21(31-26(34)35-16(2)6-7-17(35)3)11-22(25-32-27(36)37-33-25)30-23(24)19-10-20(28)13-29-12-19/h11-14,16-18,23H,4-10,15H2,1-3H3,(H,33,34,37);10-13,16-18H,3-9,14-15H2,1-2H3,(H,32,33,36);10-13,15-18H,4-9,14H2,1-3H3,(H,32,33,36)/t;;15?,16-,17-,18?/m..1/s1.
What are the key properties of 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one?
3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one has a molecular weight of 1596.18 g/mol, XLogP of 16.57, 16 rotatable bonds, 3 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-(5-chloro-3-pyridinyl)-2-[(2R,5R)-2,5-dimethylpyrrolidin-1-yl]-3-[(4-methylcyclohexyl)methyl]imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(3-methyl-1,4-oxazepan-4-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one;3-[4-(5-chloro-3-pyridinyl)-3-[(4-methylcyclohexyl)methyl]-2-(2-propan-2-ylpyrrolidin-1-yl)imidazo[4,5-c]pyridin-6-yl]-4H-1,2,4-oxadiazol-5-one is sourced from PubChem (CID 161499037), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).